| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anemia | 12 | 2021 | 789 | 2.75 | Why? |
| Blood Transfusion | 10 | 2020 | 1399 | 1.60 | Why? |
| Blood Loss, Surgical | 4 | 2019 | 211 | 1.26 | Why? |
| Preoperative Care | 5 | 2021 | 1515 | 0.81 | Why? |
| Asphyxia Neonatorum | 1 | 2019 | 17 | 0.78 | Why? |
| Gynecology | 2 | 2019 | 741 | 0.76 | Why? |
| Blood Substitutes | 1 | 2017 | 6 | 0.71 | Why? |
| Erythrocyte Transfusion | 5 | 2019 | 386 | 0.69 | Why? |
| Aprotinin | 1 | 2017 | 63 | 0.66 | Why? |
| Point-of-Care Systems | 5 | 2021 | 2955 | 0.65 | Why? |
| Thrombelastography | 3 | 2021 | 627 | 0.64 | Why? |
| Blood Banks | 2 | 2020 | 535 | 0.63 | Why? |
| Hemostatics | 2 | 2017 | 142 | 0.63 | Why? |
| Monitoring, Intraoperative | 1 | 2017 | 140 | 0.61 | Why? |
| Postoperative Hemorrhage | 1 | 2017 | 183 | 0.60 | Why? |
| Cesarean Section | 4 | 2019 | 2089 | 0.54 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2019 | 363 | 0.53 | Why? |
| Resuscitation | 2 | 2019 | 638 | 0.52 | Why? |
| Peptide Fragments | 2 | 2021 | 2075 | 0.50 | Why? |
| Anesthesiology | 3 | 2019 | 1163 | 0.46 | Why? |
| Anesthesia, General | 4 | 2020 | 470 | 0.43 | Why? |
| Wounds and Injuries | 4 | 2017 | 1708 | 0.42 | Why? |
| Hemoglobins | 5 | 2019 | 958 | 0.41 | Why? |
| Blood Coagulation Disorders | 4 | 2020 | 2040 | 0.41 | Why? |
| Airway Management | 5 | 2020 | 1298 | 0.41 | Why? |
| Xenon | 2 | 2018 | 27 | 0.37 | Why? |
| Hemorrhage | 3 | 2017 | 3013 | 0.37 | Why? |
| Blood Transfusion, Autologous | 2 | 2019 | 37 | 0.36 | Why? |
| Arachidonate 5-Lipoxygenase | 2 | 2018 | 51 | 0.36 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.34 | Why? |
| Adrenal Cortex | 1 | 2006 | 22 | 0.33 | Why? |
| Toll-Like Receptor 2 | 2 | 2019 | 198 | 0.33 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.33 | Why? |
| Antifibrinolytic Agents | 2 | 2019 | 150 | 0.32 | Why? |
| Tranexamic Acid | 2 | 2019 | 121 | 0.32 | Why? |
| Anesthesia, Spinal | 2 | 2019 | 178 | 0.31 | Why? |
| Operative Blood Salvage | 3 | 2020 | 19 | 0.30 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.29 | Why? |
| Anesthesiologists | 3 | 2021 | 614 | 0.29 | Why? |
| Myocardial Reperfusion Injury | 2 | 2019 | 129 | 0.27 | Why? |
| Reperfusion Injury | 2 | 2017 | 178 | 0.27 | Why? |
| Apoptosis | 4 | 2018 | 2335 | 0.27 | Why? |
| Toll-Like Receptors | 1 | 2006 | 365 | 0.26 | Why? |
| Postoperative Care | 2 | 2018 | 755 | 0.24 | Why? |
| Coronary Artery Bypass | 3 | 2018 | 629 | 0.24 | Why? |
| Sepsis | 4 | 2019 | 3517 | 0.24 | Why? |
| Anesthesia, Intravenous | 2 | 2018 | 37 | 0.22 | Why? |
| Postpartum Hemorrhage | 2 | 2019 | 144 | 0.21 | Why? |
| Emergency Medical Services | 4 | 2020 | 3557 | 0.21 | Why? |
| Granisetron | 1 | 2019 | 4 | 0.20 | Why? |
| Mitochondria, Heart | 1 | 2019 | 37 | 0.20 | Why? |
| Connexin 43 | 1 | 2019 | 37 | 0.20 | Why? |
| Germany | 10 | 2021 | 9196 | 0.20 | Why? |
| Surgical Procedures, Operative | 3 | 2021 | 2662 | 0.19 | Why? |
| Receptors, Lysosphingolipid | 1 | 2018 | 25 | 0.19 | Why? |
| Maltose | 1 | 2018 | 50 | 0.18 | Why? |
| Antiemetics | 1 | 2019 | 75 | 0.18 | Why? |
| Laryngoscopes | 1 | 2020 | 121 | 0.18 | Why? |
| Methyl Ethers | 1 | 2017 | 22 | 0.18 | Why? |
| Pheochromocytoma | 1 | 2018 | 32 | 0.18 | Why? |
| Thymocytes | 1 | 2017 | 11 | 0.18 | Why? |
| Lipoxygenase Inhibitors | 1 | 2017 | 18 | 0.18 | Why? |
| Trauma Centers | 2 | 2017 | 1195 | 0.18 | Why? |
| Catecholamines | 1 | 2018 | 66 | 0.18 | Why? |
| Ischemic Preconditioning | 1 | 2018 | 43 | 0.18 | Why? |
| Lysophospholipids | 1 | 2018 | 74 | 0.17 | Why? |
| Leukotrienes | 1 | 2017 | 37 | 0.17 | Why? |
| Blood Viscosity | 1 | 2018 | 71 | 0.17 | Why? |
| Embolism, Air | 1 | 2017 | 23 | 0.17 | Why? |
| Salvage Therapy | 1 | 2020 | 417 | 0.17 | Why? |
| Mandible | 1 | 2018 | 72 | 0.17 | Why? |
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 372 | 0.17 | Why? |
| Adrenal Gland Neoplasms | 1 | 2018 | 70 | 0.17 | Why? |
| Sphingosine | 1 | 2018 | 101 | 0.17 | Why? |
| Humans | 67 | 2021 | 930598 | 0.17 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.17 | Why? |
| Leukotriene Antagonists | 1 | 2017 | 37 | 0.17 | Why? |
| Endothelium | 1 | 2021 | 460 | 0.17 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.17 | Why? |
| Arthroplasty, Replacement, Hip | 2 | 2019 | 403 | 0.16 | Why? |
| Immune System | 1 | 2006 | 1479 | 0.16 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.16 | Why? |
| Thymus Gland | 1 | 2017 | 126 | 0.16 | Why? |
| Peritonitis | 1 | 2019 | 217 | 0.16 | Why? |
| Blood Coagulation Disorders, Inherited | 1 | 2017 | 82 | 0.16 | Why? |
| Craniotomy | 1 | 2017 | 123 | 0.16 | Why? |
| Cell-Derived Microparticles | 1 | 2017 | 134 | 0.16 | Why? |
| Legislation, Drug | 1 | 2017 | 101 | 0.15 | Why? |
| Platelet Transfusion | 1 | 2017 | 209 | 0.15 | Why? |
| Fibrinolysis | 1 | 2021 | 521 | 0.15 | Why? |
| Anemia, Iron-Deficiency | 1 | 2018 | 210 | 0.15 | Why? |
| Hypnotics and Sedatives | 1 | 2021 | 624 | 0.15 | Why? |
| Tracheotomy | 1 | 2021 | 427 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Evidence-Based Medicine | 3 | 2017 | 3228 | 0.15 | Why? |
| Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.15 | Why? |
| Image Enhancement | 1 | 2017 | 177 | 0.15 | Why? |
| Pregnancy Complications, Hematologic | 1 | 2017 | 114 | 0.15 | Why? |
| Licensure | 1 | 2017 | 144 | 0.15 | Why? |
| Intraoperative Care | 1 | 2017 | 238 | 0.14 | Why? |
| Pregnancy | 7 | 2020 | 23879 | 0.14 | Why? |
| Transfusion Reaction | 1 | 2017 | 245 | 0.14 | Why? |
| HELLP Syndrome | 1 | 2014 | 52 | 0.14 | Why? |
| Anesthesia, Obstetrical | 2 | 2017 | 230 | 0.14 | Why? |
| Traumatology | 1 | 2017 | 255 | 0.14 | Why? |
| Angiotensin II | 1 | 2020 | 601 | 0.14 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.14 | Why? |
| Blood Specimen Collection | 1 | 2018 | 387 | 0.13 | Why? |
| Video Recording | 1 | 2020 | 786 | 0.13 | Why? |
| Efficiency | 1 | 2017 | 420 | 0.13 | Why? |
| Cecum | 1 | 2012 | 63 | 0.12 | Why? |
| Heart Rate | 2 | 2019 | 1527 | 0.12 | Why? |
| Thyroid Gland | 1 | 2018 | 516 | 0.12 | Why? |
| Blood Coagulation Tests | 1 | 2018 | 855 | 0.12 | Why? |
| Myocytes, Cardiac | 1 | 2019 | 804 | 0.12 | Why? |
| Troponin I | 2 | 2018 | 1298 | 0.12 | Why? |
| Critical Care | 4 | 2021 | 14081 | 0.12 | Why? |
| Infusions, Intraosseous | 1 | 2011 | 36 | 0.12 | Why? |
| Aspirin | 2 | 2017 | 1043 | 0.12 | Why? |
| Blood Component Transfusion | 1 | 2017 | 740 | 0.12 | Why? |
| Microfilament Proteins | 1 | 2011 | 45 | 0.11 | Why? |
| Cell Communication | 3 | 2019 | 396 | 0.11 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Postoperative Complications | 3 | 2018 | 5861 | 0.11 | Why? |
| Needles | 1 | 2011 | 87 | 0.11 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.11 | Why? |
| Perioperative Care | 2 | 2019 | 1329 | 0.11 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.11 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2017 | 453 | 0.11 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.11 | Why? |
| Edema | 1 | 2014 | 333 | 0.11 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.11 | Why? |
| Ischemia | 1 | 2019 | 901 | 0.11 | Why? |
| Hip Fractures | 1 | 2018 | 667 | 0.11 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.10 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.10 | Why? |
| Neutrophils | 3 | 2018 | 5476 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2018 | 931 | 0.10 | Why? |
| Obstetrics | 1 | 2019 | 859 | 0.10 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2014 | 604 | 0.10 | Why? |
| Female | 29 | 2021 | 380317 | 0.10 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.10 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.10 | Why? |
| Infant, Newborn | 4 | 2020 | 23105 | 0.10 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.09 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.09 | Why? |
| Treatment Outcome | 8 | 2021 | 51732 | 0.09 | Why? |
| Radiology | 2 | 2017 | 1199 | 0.09 | Why? |
| Acute Lung Injury | 1 | 2017 | 904 | 0.09 | Why? |
| Eye Diseases | 1 | 2020 | 1150 | 0.09 | Why? |
| Male | 30 | 2021 | 367725 | 0.09 | Why? |
| Interleukins | 1 | 2014 | 762 | 0.09 | Why? |
| Carcinoma, Medullary | 1 | 2008 | 12 | 0.09 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.09 | Why? |
| Precision Medicine | 1 | 2019 | 1477 | 0.09 | Why? |
| Phosphorylation | 3 | 2019 | 1060 | 0.09 | Why? |
| Pre-Eclampsia | 1 | 2014 | 599 | 0.09 | Why? |
| Europe | 4 | 2021 | 12702 | 0.09 | Why? |
| Cell Adhesion Molecules | 1 | 2011 | 472 | 0.09 | Why? |
| Anesthesia | 1 | 2018 | 1236 | 0.09 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.09 | Why? |
| Aged | 19 | 2021 | 215776 | 0.09 | Why? |
| Orthopedic Procedures | 1 | 2019 | 1231 | 0.09 | Why? |
| Receptor Cross-Talk | 1 | 2006 | 21 | 0.09 | Why? |
| Health Resources | 1 | 2021 | 2592 | 0.08 | Why? |
| Multicenter Studies as Topic | 3 | 2019 | 2437 | 0.08 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 1454 | 0.08 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.08 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| Intubation, Intratracheal | 2 | 2020 | 3962 | 0.08 | Why? |
| Disease Models, Animal | 5 | 2019 | 10998 | 0.08 | Why? |
| Immunoglobulins, Intravenous | 1 | 2019 | 2705 | 0.08 | Why? |
| Patient Positioning | 1 | 2017 | 1505 | 0.08 | Why? |
| Surgeons | 1 | 2021 | 2233 | 0.08 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.08 | Why? |
| Algorithms | 3 | 2019 | 7346 | 0.08 | Why? |
| Health Care Rationing | 1 | 2021 | 2558 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.08 | Why? |
| Occupational Diseases | 1 | 2021 | 2787 | 0.07 | Why? |
| Publications | 1 | 2011 | 463 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 3 | 2021 | 3776 | 0.07 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.07 | Why? |
| Arrhythmias, Cardiac | 1 | 2019 | 2510 | 0.07 | Why? |
| Neuroimmunomodulation | 1 | 2006 | 154 | 0.07 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.07 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.07 | Why? |
| Aerosols | 1 | 2021 | 5393 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2018 | 1884 | 0.07 | Why? |
| Blood Coagulation | 1 | 2017 | 2768 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.06 | Why? |
| Pregnancy Complications | 1 | 2014 | 1388 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Animals | 11 | 2019 | 78931 | 0.06 | Why? |
| Lung Transplantation | 1 | 2014 | 1554 | 0.06 | Why? |
| Thyroid Neoplasms | 1 | 2008 | 422 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Mice | 6 | 2018 | 21357 | 0.06 | Why? |
| Case-Control Studies | 2 | 2019 | 17671 | 0.06 | Why? |
| Triage | 1 | 2021 | 7151 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2019 | 9091 | 0.05 | Why? |
| Thromboembolism | 1 | 2014 | 2101 | 0.05 | Why? |
| HEK293 Cells | 3 | 2021 | 8394 | 0.05 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Congresses as Topic | 1 | 2011 | 1347 | 0.05 | Why? |
| Monocytes | 2 | 2017 | 2978 | 0.05 | Why? |
| Time Factors | 6 | 2021 | 31397 | 0.05 | Why? |
| Phosphoproteins | 1 | 2011 | 4346 | 0.05 | Why? |
| Mice, Knockout | 2 | 2019 | 1815 | 0.05 | Why? |
| Blood Platelets | 1 | 2011 | 1704 | 0.05 | Why? |
| Sympathomimetics | 1 | 2019 | 22 | 0.05 | Why? |
| Neoplasms | 2 | 2018 | 17251 | 0.05 | Why? |
| Visual Fields | 1 | 2021 | 123 | 0.05 | Why? |
| Environment, Controlled | 1 | 2021 | 129 | 0.05 | Why? |
| Interferon-alpha | 1 | 2008 | 1442 | 0.05 | Why? |
| Theophylline | 1 | 2019 | 39 | 0.05 | Why? |
| Clinical Trials, Phase IV as Topic | 1 | 2019 | 75 | 0.05 | Why? |
| Equipment Design | 2 | 2020 | 3095 | 0.05 | Why? |
| Dendritic Cells | 1 | 2008 | 1330 | 0.05 | Why? |
| Neuroma | 1 | 2018 | 2 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| HCT116 Cells | 1 | 2018 | 83 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2021 | 4260 | 0.05 | Why? |
| Platelet Aggregation | 1 | 2021 | 318 | 0.05 | Why? |
| HT29 Cells | 1 | 2018 | 108 | 0.05 | Why? |
| RNA Transport | 1 | 2017 | 10 | 0.05 | Why? |
| Arachidonic Acid | 1 | 2018 | 90 | 0.05 | Why? |
| Oxytocin | 1 | 2019 | 76 | 0.05 | Why? |
| Protein Kinase C | 1 | 2018 | 58 | 0.05 | Why? |
| Liver Transplantation | 1 | 2014 | 2864 | 0.05 | Why? |
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 45 | 0.05 | Why? |
| Bcl-2-Like Protein 11 | 1 | 2017 | 4 | 0.05 | Why? |
| Intramolecular Oxidoreductases | 1 | 2018 | 38 | 0.05 | Why? |
| Berlin | 1 | 2019 | 283 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.05 | Why? |
| Adrenalectomy | 1 | 2018 | 32 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Endocrine System | 1 | 2018 | 67 | 0.04 | Why? |
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 39 | 0.04 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2018 | 70 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2021 | 867 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
| Mice, Inbred ICR | 1 | 2018 | 242 | 0.04 | Why? |
| Hemostasis, Surgical | 1 | 2017 | 29 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Water-Electrolyte Balance | 1 | 2018 | 136 | 0.04 | Why? |
| Cysteine | 1 | 2019 | 238 | 0.04 | Why? |
| Periodicals as Topic | 1 | 2011 | 1492 | 0.04 | Why? |
| Birth Rate | 1 | 2019 | 137 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Oxytocics | 1 | 2017 | 47 | 0.04 | Why? |
| Patient Simulation | 1 | 2021 | 338 | 0.04 | Why? |
| Action Potentials | 1 | 2019 | 368 | 0.04 | Why? |
| Signal Transduction | 3 | 2019 | 7207 | 0.04 | Why? |
| Inflammation | 2 | 2017 | 13255 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2018 | 391 | 0.04 | Why? |
| European Union | 1 | 2021 | 565 | 0.04 | Why? |
| Respiratory Physiological Phenomena | 1 | 2018 | 157 | 0.04 | Why? |
| Neutrophil Infiltration | 1 | 2017 | 201 | 0.04 | Why? |
| Spinal Neoplasms | 1 | 2018 | 95 | 0.04 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2018 | 350 | 0.04 | Why? |
| Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.04 | Why? |
| Anesthetists | 1 | 2018 | 186 | 0.04 | Why? |
| Anesthetics, Inhalation | 1 | 2017 | 82 | 0.04 | Why? |
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 91 | 0.04 | Why? |
| Gene Knockdown Techniques | 1 | 2017 | 347 | 0.04 | Why? |
| Lipocalin-2 | 1 | 2017 | 156 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2019 | 540 | 0.04 | Why? |
| Substrate Specificity | 1 | 2018 | 639 | 0.04 | Why? |
| Blood Preservation | 1 | 2017 | 191 | 0.04 | Why? |
| Posture | 1 | 2017 | 199 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Platelet Function Tests | 1 | 2017 | 231 | 0.04 | Why? |
| Respiration | 1 | 2021 | 729 | 0.04 | Why? |
| Intraoperative Complications | 1 | 2018 | 221 | 0.04 | Why? |
| Blood Coagulation Factors | 1 | 2017 | 223 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2019 | 10649 | 0.04 | Why? |
| Physicians | 1 | 2014 | 4214 | 0.04 | Why? |
| Thromboplastin | 1 | 2017 | 275 | 0.04 | Why? |
| Organ Preservation Solutions | 1 | 2014 | 20 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2019 | 1224 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Tissue Plasminogen Activator | 1 | 2021 | 778 | 0.03 | Why? |
| Austria | 1 | 2019 | 1259 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.03 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.03 | Why? |
| Body Weight | 1 | 2020 | 1074 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2019 | 680 | 0.03 | Why? |
| Preoperative Period | 1 | 2014 | 271 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Platelet Activation | 1 | 2017 | 660 | 0.03 | Why? |
| Ligation | 1 | 2012 | 84 | 0.03 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.03 | Why? |
| Cell Line | 2 | 2019 | 12040 | 0.03 | Why? |
| Virion | 1 | 2021 | 1444 | 0.03 | Why? |
| Iron | 1 | 2018 | 619 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Pneumonia | 3 | 2018 | 5652 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Transplantation Chimera | 1 | 2011 | 17 | 0.03 | Why? |
| Troponin | 1 | 2018 | 1058 | 0.03 | Why? |
| Arteries | 1 | 2014 | 283 | 0.03 | Why? |
| Observation | 1 | 2011 | 80 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Hygiene | 1 | 2018 | 987 | 0.03 | Why? |
| Interleukin-8 | 1 | 2017 | 964 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Dissection | 1 | 2012 | 164 | 0.03 | Why? |
| MEDLINE | 1 | 2011 | 76 | 0.03 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.03 | Why? |
| Rats, Sprague-Dawley | 1 | 2014 | 987 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.03 | Why? |
| Hemodynamics | 1 | 2019 | 1562 | 0.03 | Why? |
| Laparotomy | 1 | 2012 | 241 | 0.03 | Why? |
| Hepatitis | 1 | 2012 | 160 | 0.03 | Why? |
| Surveys and Questionnaires | 4 | 2021 | 43792 | 0.03 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.03 | Why? |
| Operating Rooms | 1 | 2021 | 1841 | 0.03 | Why? |
| End Stage Liver Disease | 1 | 2014 | 418 | 0.02 | Why? |
| Journal Impact Factor | 1 | 2011 | 134 | 0.02 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.02 | Why? |
| Hospitals | 2 | 2018 | 11793 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Pain Measurement | 1 | 2011 | 533 | 0.02 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 47 | 0.02 | Why? |
| Linear Models | 1 | 2014 | 1914 | 0.02 | Why? |
| Interleukin-6 | 2 | 2017 | 7522 | 0.02 | Why? |
| CD56 Antigen | 1 | 2008 | 193 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Cell Movement | 1 | 2011 | 695 | 0.02 | Why? |
| Antigen-Presenting Cells | 1 | 2008 | 206 | 0.02 | Why? |
| Hypersensitivity, Delayed | 1 | 2008 | 81 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Cough | 1 | 2021 | 4891 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Rats | 1 | 2014 | 2764 | 0.02 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2020 | 1876 | 0.02 | Why? |
| Cytotoxicity, Immunologic | 1 | 2008 | 287 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.02 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
| Patient Selection | 1 | 2019 | 4560 | 0.02 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2017 | 2093 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Infant | 2 | 2020 | 30274 | 0.02 | Why? |
| Thrombosis | 2 | 2017 | 7504 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Phenotype | 1 | 2014 | 4037 | 0.02 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.02 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.02 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2019 | 4927 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2019 | 7330 | 0.01 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.01 | Why? |
| Hypoxia | 1 | 2014 | 3626 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2014 | 7972 | 0.01 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Length of Stay | 1 | 2014 | 11042 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Cytokines | 1 | 2014 | 15010 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2008 | 5837 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Child, Preschool | 1 | 2011 | 36283 | 0.01 | Why? |
| Vaccination | 1 | 2008 | 19050 | 0.00 | Why? |